Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Cash from Investing Activities (2017 - 2025)

MedWellAI (MWAI) has disclosed Cash from Investing Activities for 9 consecutive years, with -$750.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 99.75% to -$750.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $545688.0, a 79.38% decrease, with the full-year FY2025 number at $1.2 million, down 71.44% from a year prior.
  • Cash from Investing Activities was -$750.0 for Q4 2025 at MedWellAI, up from -$7308.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.4 million in Q4 2023 to a low of -$5.3 million in Q2 2021.
  • A 5-year average of -$135262.8 and a median of $348561.5 in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: plummeted 10813.25% in 2021, then skyrocketed 461.08% in 2023.
  • MedWellAI's Cash from Investing Activities stood at -$497126.0 in 2021, then surged by 149.61% to $246634.0 in 2022, then surged by 461.08% to $1.4 million in 2023, then crashed by 121.57% to -$298535.0 in 2024, then soared by 99.75% to -$750.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Cash from Investing Activities are -$750.0 (Q4 2025), -$7308.0 (Q3 2025), and $27892.0 (Q2 2025).